deflazacort
Selected indexed studies
- Comparing Deflazacort and Prednisone in Duchenne Muscular Dystrophy. (J Neuromuscul Dis, 2022) [PMID:35723111]
- [Deflazacort-induced Steven-Johnson syndrome: a case report and literature review]. (Zhonghua Er Ke Za Zhi, 2024) [PMID:39429084]
- Deflazacort. (J Postgrad Med, 2009) [PMID:20083885]
_Worker-drafted node — pending editorial review._
Connections
deflazacort is a side effect of
Sources
- Comparing Deflazacort and Prednisone in Duchenne Muscular Dystrophy. (2022) pubmed
- [Deflazacort-induced Steven-Johnson syndrome: a case report and literature review]. (2024) pubmed
- Deflazacort. (2009) pubmed
- Deflazacort--an alternative to prednisolone? (1999) pubmed
- Deflazacort: therapeutic index, relative potency and equivalent doses versus other corticosteroids. (2017) pubmed
- A Review of Deflazacort for Patients With Duchenne Muscular Dystrophy. (2020) pubmed
- Deflazacort vs prednisone treatment for Duchenne muscular dystrophy: A meta-analysis of disease progression rates in recent multicenter clinical trials. (2020) pubmed
- Deflazacort. A review of its pharmacological properties and therapeutic efficacy. (1995) pubmed
- Meta-analyses of deflazacort versus prednisone/prednisolone in patients with nonsense mutation Duchenne muscular dystrophy. (2021) pubmed
- Deflazacort: a glucocorticoid with few metabolic adverse effects but important immunosuppressive activity. (2007) pubmed